glp 1 tirzepatide patches Future of GLP-1 for Metabolic Treatment Do GLP-1 Patches Really Work?

For patients categorized as slower responders to the existing maximum dose of 15mg, these investigational doses may offer the breakthrough needed

It has not been confirmed in humans at standard doses

Ella atiende a pacientes en UCHealth University of Colorado Hospital y tambin es profesora en la University of Colorado Anschutz School of Medicine

Kedees MH, Guz Y, Grigoryan M, Teitelman G

In the Phase 3 trial SURMOUNT-1 by Jastreboff et al., 2022, the authors reported a mean weight reduction of 16.0 percent (5 mg) to roughly 22.5 percent (15 mg) versus about 3.1 percent on placebo at 72 weeks across n=2539 trial participants